or Try an Advanced Search...

    Technical Analysis for MIST - Milestone Pharmaceuticals Inc.

    Grade Last Price % Change Price Change
    C 1.86 -0.12% 0.00
    MIST closed up 6.9 percent on Wednesday, November 20, 2024, on 2.15 times normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical MIST trend table...
    Date Alert Name Type % Chg
    MACD Bullish Signal Line Cross Bullish -0.12%
    Wide Bands Range Expansion -0.12%
    MACD Bearish Signal Line Cross Bearish 6.77%
    Golden Cross Bullish 6.77%
    Boomer Buy Setup Bullish Swing Setup 6.77%
    NR7 Range Contraction 6.77%
    NR7-2 Range Contraction 6.77%
    Wide Bands Range Expansion 6.77%
    NR7 Range Contraction 9.28%
    Wide Bands Range Expansion 9.28%
    Older End-of-Day Signals for MIST ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Support 11 minutes ago
    Down 3% 11 minutes ago
    1.5x Volume Pace about 3 hours ago
    Down 2 % about 3 hours ago
    Down 1% about 3 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    MIST Chart by TradingView
    Basic chart:

    Profile

    Milestone Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes drugs for the treatment of cardiovascular indications. It offers Etripamil that completed Phase 2 clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as for treating Atrial Fibrillation and Angina. The company was founded in 2003 and is headquartered in Montréal, Canada.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Cardiology Cardiac Arrhythmia Atrial Fibrillation Angina Circulatory System Cardiovascular System Tachycardia Ventricular Tachycardia

    Is MIST a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 19 After Golden Cross, Milestone Pharmaceuticals (MIST)'s Technical Outlook is Bright
    Oct 9 Individual investors account for 54% of Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) ownership, while institutions account for 46%
    Sep 24 Milestone Pharmaceuticals to Host Investor KOL Event
    Sep 6 Milestone Partner Ji Xing Pharmaceuticals Ltd Announces Positive Topline Results from the Phase 3 Study of Etripamil in PSVT in China
    Sep 4 Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors
    Sep 3 Milestone® Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
    Aug 26 Milestone® Pharmaceuticals to Present Data on Etripamil at the ESC Congress 2024
    Aug 22 Milestone wins Buy at Rodman & Renshaw on potential Cardamyst approval
    Aug 9 Milestone Pharmaceuticals GAAP EPS of -$0.14
    Jul 31 Milestone® Pharmaceuticals to Present at the Upcoming BTIG Virtual Biotechnology Conference
    See more MIST news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.52
    52 Week Low 1.12
    Average Volume 286,683
    200-Day Moving Average 1.56
    50-Day Moving Average 1.57
    20-Day Moving Average 1.67
    10-Day Moving Average 1.84
    Average True Range 0.13
    RSI (14) 64.79
    ADX 32.5
    +DI 32.02
    -DI 17.30
    Chandelier Exit (Long, 3 ATRs) 1.71
    Chandelier Exit (Short, 3 ATRs) 1.79
    Upper Bollinger Bands 2.07
    Lower Bollinger Band 1.27
    Percent B (%b) 0.74
    BandWidth 48.18
    MACD Line 0.08
    MACD Signal Line 0.08
    MACD Histogram 0.0028
    Fundamentals Value
    Market Cap 62.28 Million
    Num Shares 33.5 Million
    EPS -1.38
    Price-to-Earnings (P/E) Ratio -1.35
    Price-to-Sales 12.28
    Price-to-Book 1.87
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.13
    Resistance 3 (R3) 2.12 2.01 2.09
    Resistance 2 (R2) 2.01 1.94 2.02 2.07
    Resistance 1 (R1) 1.94 1.90 1.97 1.95 2.05
    Pivot Point 1.83 1.83 1.85 1.84 1.83
    Support 1 (S1) 1.76 1.76 1.79 1.77 1.67
    Support 2 (S2) 1.65 1.72 1.66 1.65
    Support 3 (S3) 1.58 1.65 1.64
    Support 4 (S4) 1.59